© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Vir Biotechnology, Inc. (VIR) shows an Average True Range (ATR) of 0.69 and an Enterprise Value of 961.88M. Its average trading volume over the past 3 months is 2.56M, indicating liquidity. These fundamental metrics provide insight into VIR's underlying financial health and market activity.
| ATR | 0.69 |
| Enterprise Value | 961.88M |
| Avg Vol (3 Months) | 2.56M |
| Avg Vol (10 Days) | 9.26M |
Vir Biotechnology, Inc. (VIR) technical indicators as of February 26, 2026: the SMA 20 is 29.19%, SMA 50 at 45.14%, and SMA 200 at 74.07%. The RSI 14 value is 75.9, suggesting its current momentum. These technical analysis signals help assess VIR's price trends and potential future movements.
| SMA 20 | 29.19% |
| SMA 50 | 45.14% |
| SMA 200 | 74.07% |
| RSI 14 | 75.9 |
Vir Biotechnology, Inc. (VIR) stock performance overview as of February 26, 2026: The 52-week high is $10.94 (currently -2.82% below), and the 52-week low is $4.16 (currently 140.67% above). Over the past year, VIR's performance is -40.3%, compared to the S&P 500's 10.91% change.
| 52-Week High | 10.94 |
| 52-Week High Chg | -2.82% |
| 52-Week Low | 4.16 |
| 52-Week Low Chg | +140.67% |
| S&P 500 52-Week Chg | 10.91% |
According to market data, Vir Biotechnology, Inc. (VIR) stock's recent performance metrics show that over the last month, VIR is -2.28%, with a Year-to-Date (YTD) performance of -0.5%. Over the past year, the stock has seen a -40.3% change. These figures summarize VIR's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 10.94 | 10.94 | 10.94 | 10.94 | 10.94 | 10.94 |
| Low | 7.26 | 6.86 | 5.45 | 4.35 | 4.16 | 5.55 |
| Performance | +1.35% | -2.28% | +3.81% | +8.70% | -40.30% | -0.50% |
According to current financial data, VIR stock's P/E (TTM) ratio is -3.31, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for VIR, including P/S (21.16), P/B (1.90), and P/FCF (-3.70), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | VIR | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -3.31 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | 21.16 | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 1.9 | 0 | 9 | 5.26 |
| P/FCF (TTM) | -3.7 | -0.09 | -253.28 | 30.85 |